Effect of intestinal production of equol on menopausal symptoms in women treated with soy isoflavones
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Objective: To evaluate the effect of soy isoflavones on menopausal symptoms in women who do and who do not produce equol, a daidzein metabolite. Method: A randomized, double‐blind, placebo‐controlled clinical trial was conducted over 6 months with 96 healthy menopausal women. After taking take 135 mg of isoflavones daily for 1 week, the women in the study group were assigned to the equol‐producing (EP) or the non‐EP group according to the presence or absence of equol in their urine. Menopausal symptoms were evaluated using a modified Kupperman Index. Result: Compared with the placebo group, the scores for hot flashes and excessive sweating were significantly reduced after 3 months, and the scores for weakness, palpitations, limb paresthesia, and total symptoms after 6 months, in the EP group only. Conclusions: Isoflavone supplementation improves menopausal symptoms only in women with the ability to produce equol.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Setchell, K. D. R., Brown, N. M., & Lydeking-Olsen, E. (2002) · The Journal of Nutrition · doi:10.1093/jn/132.12.3577 · Cited by 1,209 · cited 2×
“Genestein and daidzein are themost abundant phytoestrogens in soy products but equol, a daidzein metabolite, is what is thought to have the most important estrogenic effect [5].”
BackgroundGold, E. B. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.5.463 · Cited by 861
Hot Flashes: Epidemiology and Physiology a
KRONENBERG, F. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb30316.x · Cited by 601
Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes
MacLennan, A. H., Broadbent, J. L., Lester, S., & Moore, V. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002978.pub2 · Cited by 543
Cited by
Křížová, L., Dadáková, K., Kašparovská, J., & Kašparovský, T. (2019) · Molecules · doi:10.3390/molecules24061076 · Cited by 692
Mayo, B., Vázquez, L., & Flórez, A. B. (2019) · Nutrients · doi:10.3390/nu11092231 · Cited by 416
“Conceivably, these subjects might be the only ones who would benefit from soy or isoflavone consumption [111,123,124].”
BackgroundPhytoestrogens for menopausal vasomotor symptoms
Lethaby, A., Marjoribanks, J., Kronenberg, F., Roberts, H., Eden, J., & Brown, J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001395.pub4 · Cited by 287
Complementary and Alternative Medicine for Menopause
Johnson, A., Roberts, L., & Elkins, G. (2019) · Journal of Evidence-Based Integrative Medicine · doi:10.1177/2515690x19829380 · Cited by 256
Soy, Red Clover, and Isoflavones and Breast Cancer: A Systematic Review
Fritz, H., Seely, D., Flower, G., Skidmore, B., Fernandes, R., Vadeboncoeur, S., Kennedy, D., Cooley, K., Wong, R., Sagar, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081968 · Cited by 188
“In vivo, formononetin is metabolized to daidzein [30], which may be metabolized to equol among equol producers [31-33].”
Background
Metadata
- Authors
- Jou, H., Wu, S., Chang, F., Ling, P., Chu, K. S., & Wu, W.
- Venue
- International Journal of Gynecology & Obstetrics
- Publisher
- Wiley
- Published
- 2008-04-08
- Volume
- 102
- Issue
- 1
- Pages
- 44-49
- ISSN
- 0020-6695 (ISSN-L)
- 0020-7292
- 1879-3479
- OpenAlex
- W2004670485
- Cited by
- 89
- References
- 4
- FWCI
- 4.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of intestinal production of equol on menopausal symptoms in women treated with soy isoflavones. https://app.cochat.ai/papers/10.1016/j.ijgo.2008.01.028
- The paper
- Jou, H., Wu, S., Chang, F., Ling, P., Chu, K. S., & Wu, W. (2008). Effect of intestinal production of equol on menopausal symptoms in women treated with soy isoflavones. International Journal of Gynecology & Obstetrics. https://doi.org/10.1016/j.ijgo.2008.01.028
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.